Vanguard Portfolio Management’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.8M Buy
1,893,279
+67,680
+4% +$596K ﹤0.01% 1971
2026
Q2
$14.8M Buy
1,825,599
+90,950
+5% +$666K ﹤0.01% 2075
2026
Q1
$11.1M Buy
+1,734,649
New +$11.2M ﹤0.01% 2088

Other funds holding PBYI

Vanguard Portfolio Management's PBYI Position: Q3 2026 in Review

Vanguard Portfolio Management increased its Puma Biotechnology (PBYI) stake by 3.7% in Q3 2026, buying an estimated $596K and bringing the position to 1,893,279 shares worth $18.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1971.

Vanguard Portfolio Management first reported a position in PBYI in Q1 2026 and has held it in 3 quarters since. 123 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • Vanguard Portfolio Management held 1,893,279 shares of Puma Biotechnology worth $18.8M as of Q3 2026.
  • Vanguard Portfolio Management bought 67,680 Puma Biotechnology shares in Q3 2026, an estimated $596K.
  • Puma Biotechnology made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1971 holding.
  • Vanguard Portfolio Management first reported a position in Puma Biotechnology in Q1 2026 and has held it in 3 quarters since.
  • 123 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.